GLOMERULAR PERMSELECTIVITY is mainly thought to be regulated at the level of the glomerular basement membrane and/or the podocyte slit diaphragm. The endothelial cells of the glomerulus are highly fenestrated and, thus, have not been considered to have prominent restrictive properties. However, recent findings suggest that the glomerular endothelial fenestrae may indeed be covered by a diaphragm similar to the diaphragm that covers fenestrae of other capillary beds (33) . The protein PV-1, a component of the diaphragms of fenestrae and caveolae, is not present in the glomerular endothelium (40) (41) (42) . Therefore, the glomerular endothelium may have properties different from those of other fenestrated capillary beds.
Earlier studies show a thick cell coat (glycocalyx) covering the endothelial cells (25, 29, 32, 46) . The cell coat is a matrix-like gel composed of proteoglycans, with negatively charged as well as neutral glycosaminoglycans (GAGs), glycoproteins, and plasma proteins. In particular, the plasma protein orosomucoid seems to be vital for maintaining normal capillary permeability (8, 11, 12) . Previously, our laboratory also demonstrated that orosomucoid is produced by endothelial cells (37) . The negatively charged components are abundant in this gel-like cell coat, which is suggested to constitute at least part of the charge barrier in the kidney and other organs (1, 38, 39, 46) .
The production of GAGs by the glomerular cells was first reported in the early 1980s (18) . Most studies have dealt with the mesangial and epithelial cells; only a few studies have focused on the glomerular endothelial cells (GECs). Kasinath (21) studied sulfated GAGs produced by GECs under control conditions and in the presence of transforming growth factor-␤1 (TGF-␤1). TGF-␤1 caused an almost twofold increase in the synthesis of GAGs. Moreover, it was shown that the endothelial cells synthesize not only heparan sulfate but also chondroitin and dermatan sulfate (21, 35) . Other studies measured the GAG synthesis and turnover in vitro and in vivo and in response to puromycin aminonucleoside (PAN). Akuffo et al. (2) found that glomerular GAGs mainly in the glomerular basement membrane and mesangial matrix have a more rapid turnover rate than GAGs in other tissues. They also observed a decrease in GAG turnover rate in rats in response to PAN at day 5 of treatment, when proteinuria was significant. A similar finding was reported earlier for the glomerular basement membrane by Garin and Shirey (10) . In another study, it was shown that the glycocalyx covering the endothelial cells contains the GAG hyaluronan, which is needed to maintain a selective barrier to macromolecules (14) .
Our concern was that because so few reports deal with the endothelial cell coat as a part of the permselective barrier in the glomeruli, its involvement in certain pathological conditions of the kidney could have been overlooked. To address this concern, we treated cultures of bovine GECs with PAN or interleukin (IL)-1␤ to assess whether the synthesis of sulfated GAGs was altered in any way. PAN was chosen because it has previously been extensively used to induce a nephrosis-like condition in vivo in the rat (30, 34) . IL-1␤ is a cytokine with a wide variety of proinflammatory actions, such as endothelial cell activation and induction of leukocyte adhesion molecules and other cytokines, as well as inducible nitric oxide synthase (9) . Several studies have shown that IL-1 increases the amount of GAG synthesis by glomerular cells (20, 26, 44) . In addition, it has been shown that increased biosynthesis of GAGs enhances glomerular injury (6, 45) .
Our primary goal was to analyze the hydrodynamic size and chemical composition of the molecules produced by the endothelial cells. The rate of production over time was also studied and compared with that in the presence of PAN or IL-1␤.
METHODS

Medium and reagents.
GECs were cultured in culture flasks (Costar, Cambridge, MA) in a humidified, 5% CO 2 atmosphere at 37°C. The culture flasks were coated with attachment factor (gelatin; Cascade Biologics, Portland, OR). RPMI 1640 medium was supplemented as follows: penicillin, streptomycin, and amphotericin B (Cascade Biologics), 20% fetal calf serum (FCS), bovine fibroblast growth factor (acidic, 8 ng/ml for cloning medium and 4 ng/ml for growth medium; R & D Systems), bovine brain extract (700 l from stock solution; BioWhittaker, Vä stra Frölunda, Sweden), and heparin (2 g/ml; Lövens, Malmö, Sweden). Trypsin (0.125%; Life Technologies, Tä by, Sweden) was used for passaging of the cells, and collagenase (type IV, Sigma, St. Louis, MO) was used to digest the whole glomeruli. Stainless steel sieves (180, 106, and 75 m; Endecotts, London, UK) were used to extract the glomeruli.
Isolation of glomeruli. Kidneys from calves younger than 1 yr were obtained from a slaughterhouse; within minutes after harvest, they were placed in medium containing antibiotics and stored on ice. Within 1 h after harvesting of the kidney, glomeruli were isolated and treated with collagenase to obtain single cells and cell clusters according to the protocol described by Ballermann (5) . The pellet containing single cells and cell clusters was resuspended in cloning medium and plated onto gelatin-coated petri dishes. When the endothelial cell colonies had reached ϳ300 cells, they were transferred to 24-well plates by the use of cloning cylinders. The cells were subcloned in the event that pure cultures were not obtained the first time. When the cells were confluent, they were passaged and moved to 25-cm 2 flasks, and the medium was changed to growth medium.
Immunohistochemistry. The cells were grown in chamber slides (Becton Dickinson) precoated with gelatin (Cascade Biologics) until they reached 70% confluence. The cells were rinsed briefly with 0.01 M PBS-0.01% Triton X-100, pH 7.4, and fixed with 4% paraformaldehyde-PBS, pH 7.4, for 15 min at room temperature. After fixation, the cells were rinsed with PBS-Triton X-100 for 20 min. The cells were incubated in 50 mM NH 4Cl in 0.01 M PBS-0.15 M NaCl, pH 7.4, to block aldehyde groups. After they were rinsed, the cells were treated with 0.1% Triton X-100-PBS for 30 min and incubated with 5% low-fat milk in PBS for 1 h at room temperature. Primary human von Willebrand factor antibody (rabbit monoclonal; catalog no. F-3520, Sigma), diluted 1:500 in the blocking solution, was applied, and the cells were incubated for 1 h at room temperature. As a control for contaminating cells in the culture, smooth muscle ␣-actin antibody (mouse monoclonal; catalog no. A-2547, Sigma), diluted 1:400, was used under the conditions described above. As a negative control, we used cells in which incubation with the primary antibody was replaced by incubation with rabbit or mouse nonspecific IgG (Sigma), and a different cell type (rat cardiomyocytes) was incubated as described above for the GECs. The cells were incubated with secondary antibodies conjugated with horseradish peroxidase (HRP; Amersham Pharmacia Biotech, Uppsala, Sweden) for 1 h and then developed with diaminobenzidine-H2O2.
Further characterization of the cells using acetylated lowdensity lipoprotein. The cells were treated with trypsin and seeded onto chamber slides (Falcon, Becton Dickinson, Meylan Cedex, France) precoated with gelatin (Cascade Biologics). The cells were allowed to grow under normal conditions until they reached 70% confluence. The medium was removed, and 0.3 ml of acetylated low-density lipoprotein (DilAc-LDL; Biomedical Technologies, Stroughton, MA), diluted to 10 g/ml in RPMI medium, was added to each well. After incubation for 3 h at 37°C, the cells were washed briefly three times with 0.01 M PBS, pH 7.4. The cells were fixed with 3% formaldehyde for 20 min on a rotary shaker at room temperature and then washed once with PBS. The PBS and the chamber wells were removed, and the cells were mounted. The cells were examined by fluorescence microscopy at 570 nm.
Biosynthesis of GAGs. GAG biosynthesis by GECs was measured by a modification of the method of Arisaka et al. (3) . The cells (P6) were allowed to grow to 70% confluence in 75-cm 2 culture flasks (Costar, Cambridge, MA) before they were stimulated with 1 nM PAN (Sigma) or 10 or 20 U/ml IL-1␤ (Sigma). Eight 75-cm 2 culture flasks were used for each concentration. As control, we used eight flasks of nonstimulated cells grown under normal conditions. Stimulation was performed for 24 h at 37°C in a humidified, 5% CO2 atmosphere. The cells were "starved" in standard medium with 2% FCS and half of the amount of bovine brain extract during the study. For metabolic labeling of GAGs, 35 S-labeled sodium sulfate (10 Ci/ml; NEX041, NEN, Boston, MA) was added to each flask after initial treatment with the test substances for 24 h. Conditioned media from the cell flasks were collected 12, 24, 36, and 48 h after the 35 S-labeled sodium sulfate was added. At 72 h, after the cells were washed extensively with Hanks' balanced salt solution, cell layers were scraped off and the resultant cell suspension was centrifuged. The protein content of the cell fraction was measured by the method of Lowry et al. (24) .
HPLC analysis of the cell culture media. The samples from the cell culture media at different hours of stimulation were fractionated (BioSep SEC-S3000 column, Phenomenex, Torrance, CA) according to molecular size as follows: 41-50, 50-59, 59-69, 69-79, 79-90, 90-102, and Ͼ102 Å. Then each sample was placed in a vial with fresh quenching fluid and analyzed for 10 min in a beta counter (model L6 6500, Beckman). Calibrated standards were analyzed after every 16th sample to allow accurate estimations of Stokes-Einstein (SE) radii.
Enzyme digestion of proteoglycans. Three different enzymes known to degrade proteoglycans were used to treat the final media samples (taken at 72 h). After digestion, the samples were fractionated in an HPLC (see HPLC analysis of the cell culture media). After fractionation, the samples were analyzed using a scintillation counter for assessment of the amount of degraded GAGs compared with the same sample without enzyme treatment.
Chondroitin ABC lyase (EC 4.2.2.4, Sigma; dissolved in 1 M Tris ⅐ HCl, pH 8.0), which degrades chondroitin and dermatan sulfate, in a final concentration of 0.1 U/ml was incubated with the samples for 2 h at 37°C.
Heparinase III (EC 4.2.2.8, Sigma; dissolved in 0.1 M sodium acetate, pH 7.0) in a final concentration of 50 mU/ml was incubated with the samples for 4 h at 37°C.
Hyaluronidase (EC 3.2.1.35, Sigma; dissolved in sodium phosphate buffer ϩ 0.15 M NaCl, pH 6.0) in a final concentration of 1 mg/ml was incubated with the samples for 1 h at 37°C. This enzyme degrades hyaluronan and chondroitin sulfate (A and C), but because hyaluronan does not contain sulfate, the treatment will reveal the chondroitin sulfate component of the GAGs.
All three enzyme reactions were ended by lowering the temperature to Ϫ20°C.
Western blot. The proteins were denatured and then separated on a 10% Bis-Tris polyacrylamide gel (Nupage, Novex, San Diego, CA), which was run at 200 V for 35 min. The proteins were then blotted onto a polyvinylidene difluoride membrane (Novex) in a standard manner (3 h at 25 V and 0.25 A). After transfer, the membrane was blocked for 1 h at room temperature in 5% nonfat dry milk-0.25% gelatin dissolved in Tris-buffered saline (10 mM Tris ⅐ HCl, pH 7.5, and 150 mM NaCl) with 0.1% Tween. The membrane was incubated for 1 h at room temperature with a primary bovine heparan sulfate proteoglycan antibody (mouse monoclonal IgG1, Biogenesis, Poole, UK) diluted 1:100 in the blocking solution. After the membrane was rinsed in TBS-0.1% Tween, it was incubated with a secondary antibody conjugated with HRP (anti-mouse HRP, Amersham). The proteinantibody complexes were visualized by enhanced chemiluminescence (ECLϩ and Hyperfilm ECL, Amersham) according to the manufacturer's instructions.
RT-PCR. Synthesis of cDNA was carried out with 1 g of RNA from GEC; as positive control, we used RNA from bovine kidney. The RT reaction was carried out for 50 min at 42°C and for 5 min at 70°C in RT buffer (Promega, Madison, WI) in the presence of 1 g of random primer (Promega), 15 U of avian myeloblastosis virus RT (Promega), 20 U of RNasin (Promega), and dNTP mix (1.5 mM of each base) in a total volume of 20 l. PCR amplification was performed in a 50-l reaction buffer with 5 l of the cDNA used as a template, PCR buffer [50 mmol/l KCl, 10 mmol/l Tris ⅐ HCl (pH 8.3), 1.5 mmol/l MgCl 2, and 0.001% (wt/vol) gelatin (Perkin-Elmer Cetus, Norwalk, CT)], 0.2 mol/l of each forward and reverse heparan sulfate primer (oci5), dNTP (10 nM each), and 2.5 U of Taq DNA polymerase (Promega). The following PCR program was used: 94°C for 4 min (94°C for 15 s, 54°C for 15 s, 72°C for 30 s) for 30 cycles and 72°C for 10 min (GeneAmp PCR System 2400, Perkin-Elmer). The sequences of the heparan sulfate primers were as follows: 5Ј AAC TAC CCA AGC CTG ACT CCA C 3Ј (forward) and 5Ј ATC TCC ACC ACA CCT GCC ATA C 3Ј (reverse) with a product size of 479 bp. The primers were located between 541-562 (forward) and 998-1,019 (reverse) bp in the human heparan sulfate cDNA sequence.
RESULTS
GEC culture. After ϳ7 days, the glomerular cells started to appear as small colonies of different morphology, of which about one of five was of endothelial origin. After 12 days, we observed clones large enough for transfer to a 24-well plate (Fig. 1A) . The cells were of endothelial origin as judged by light microscopy and by endocytosis of the endothelial cell-specific marker Dil-Ac-LDL as observed by fluorescence microscopy (Fig. 1B) and expression of factor VIII-related antigen. The cells stained negatively for smooth muscle ␣-actin, and no staining was observed for Dil-Ac-LDL or factor VIII-related antigen in the negative controls.
GAG synthesis. The fractionated cell media showed that most incorporated radioactivity in the control cultures was in the hydrodynamic radius range of 70-90 Å. During the control period, there was a gradual increase in the concentration of incorporated radioactivity from 12 to 42 h (mean of 36-and 48-h samples) of 66 Ϯ 6% (n ϭ 8, P Ͻ 0.01). At 12 h, three groups contained similar amounts of sulfated GAGs, namely, controls 3,180 Ϯ 270 cpm/ml, puromycin 3,900 Ϯ 270 cpm/ml, and IL-1␤ (10 U/ml) 3,820 Ϯ 590 cpm/ml, while IL-1B (20 U/ml) was significantly increased already at 10 min (5,800 Ϯ 660 cpm/ml). Treatment with PAN reduced the concentration by 31 Ϯ 1%, P Ͻ 0.001, n ϭ 8, during the same time period. IL-1␤, on the other hand, increased the synthesis of sulfated macromolecules significantly compared with control during the entire time period (Fig. 2) . At 48 h, the concentration of 35 S-labeled GAGs was twice as high as at 12 h for both IL-1 treatment groups (10 and 20 U/ml, P Ͻ 0.01, n ϭ 8). Moreover, treatment with IL-1␤ (10 U/ml) gave a value of 9,200 Ϯ 570 cpm/ml at 42 h.
The mean of incorporated sulfate in all four groups distributed among SE radii reveals the same pattern of incorporation as in Fig. 2 , and most incorporated sulfate was found in the fractions of large molecules (SE radius ϭ 70-90 Å; Fig. 3) .
Enzyme treatments. After enzyme treatment, we found most of the cell medium activity in the fractions containing small molecules, confirming that the large proteoglycans had been degraded (Fig. 4) .
Compared with the enzyme-free solutions, we noted a reduction of 35 S activity in the fractions containing larger molecules (SE radii Ͼ69 Å). Similar patterns were seen in the controls and IL-1␤ groups, and the data were pooled. Because PAN treatment lowered the rate of incorporation of sulfate, the activity was not high enough to allow us to determine the effects of the enzymes in this group. Cell medium treated with chondroitinase ABC contained 54 Ϯ 3% of control (P Ͻ 0.001), medium treated with heparinase III contained 69 Ϯ 2% of control (P Ͻ 0.001), and medium treated with hyaluronidase contained 76 Ϯ 6% of control (P Ͻ 0.01). The latter enzyme degrades hyaluronan, which is nonsulfated, and chondroitin sulfate; chondroitinase ABC degrades chondroitin and dermatan sulfate. This means that heparan sulfate accounts for 30.6%, chondroitin sulfate for 23.8%, and dermatan sulfate for 22.6% of the total amount of GAGs (Fig. 5) .
Protein synthesis. The protein concentrations were similar for the different groups (n ϭ 8 in each group), indicating similar numbers of cells and no apparent general toxicity of the drugs (Fig. 6) . ଝ P Ͻ 0.05; ଝଝ P Ͻ 0.01. Fig. 3 . Cell medium activity of incorporated 35 S for the 7 molecular fractions. Bars represent means of 4 collections (from 24-48 h). Synthesis was decreased in PAN-treated group and increased in IL-1␤-treated groups, as in Fig. 2. PCR. The expression of heparan sulfate proteoglycan mRNA from the different groups of GEC and cortex from whole kidney was examined by RT-PCR. Transcripts of the expected size (479 bp) were found in all samples (data not shown).
Western blot. Western blot analysis of heparan sulfate proteoglycan was performed, and 55-kDa bands in the protein extracts from the GECs indicate that heparan sulfate core protein was present in all treatment groups (Fig. 7) .
DISCUSSION
The production of GAGs by GECs has been far less studied than GAG synthesis by epithelial and mesangial cells. In this study, we demonstrate that PAN and IL-1␤ affect GAG synthesis in the GECs. Thus the amount of metabolic labeling was decreased in the PAN-treated cell cultures. When the cells were stimulated with IL-1␤, an increase in metabolic labeling was observed. Because the protein concentrations were similar in the different treatment groups (Fig. 6) , it was mainly the degree of sulfation that was affected. The 35 S-labeled GAG content of the culture medium was fractionated according to size by HPLC. When examining the size distribution of the samples, we found a peak at 50-90 Å. In all molecular size fractions, we found a decreased synthesis of GAGs after treatment with PAN and an increased synthesis after IL-1␤ treatment. The pattern was most pronounced in the fractions of the largest molecules (Ͼ70 Å). This fits well with the notion that proteoglycans are large molecules, consisting of a core protein with GAG chains, such as heparan sulfate, attached (13, 23) . The sulfation is carried out by several isoenzymes, and the reactions are often incomplete, leading to a large variation in sulfation of the heparan sulfate GAGs (22, 31) .
The time-course study showed that the PAN effect had a slower onset than the IL-1␤ effect. The significant reduction induced by PAN after 36 h remained at this low level at 48 h. The high dose of IL-1␤ induced a significant increase at 12 h (P Ͻ 0.05), and the concentration of sulfated GAGs continued to rise during the time course of the study (P Ͻ 0.01). The lower dose of IL-1␤ (10 U/ml) resulted in no significant increase at 12 h, but thereafter the pattern was similar to the higher dose (20 U/ml). For the control cells, the concentration of sulfated GAGs increased slightly during the experiment (Fig. 2) . In addition, we examined the presence of mRNA for heparan sulfate in the RNA obtained from the cells. All groups showed expression of heparan sulfate mRNA. We also obtained evidence for heparan sulfate core protein synthesis by the cells.
It is known that human umbilical vein endothelial cells produce mainly heparan sulfate (29) . However, in a study investigating GECs, it was shown that mainly chondroitin sulfate chains were attached to the core proteins of the proteoglycans (35) . This difference in expression of GAGs could be interpreted as macro-and microvascular endothelium reflecting different characteristics, as previously noted by Zetter (48) . We found that three main GAGs were present in bovine GECs: heparan, chondroitin, and dermatan sulfate (Fig. 5) .
PAN causes nephrotic syndrome in rats when administered intraperitoneally (19, 27, 30, 34) . It is therefore interesting to note that the drug also downregulates the incorporation and synthesis of GAGs by the endothelial cells. The endothelial cell coat (27, 30, 34) has been suggested to contribute to the permselective properties of the capillaries (1, 17, 38, 39, 47) . A decreased synthesis of GAGs could increase permeability of the layer covering the fenestrae and, thus, increase the sieving of macromolecules (14) . It has previously been shown that PAN has effects on the GEC fenestrations, which were decreased in size and amount during PAN-induced nephrosis (4). Thus, during certain pathological conditions, the charge barrier may be reduced as a result of a decreased amount of negatively charged components of the endothelial cell coat. This is in line with previous observations from our group where we showed that orosomucoid, a glycoprotein known to be important for the glomerular permselectivity [probably because of its high negative charge (1, 11, 12) ], was synthesized by the endothelial cells (37) . Thus it seems that the GECs can modify their expression and turnover of cell coat components in response to different stimuli. The importance of the GAGs is illustrated in a study where the gene for the enzyme responsible for sulfation (heparan sulfate 2-O-sulfotransferase) of heparan sulfate was knocked out. The mice did not develop kidneys as a result of failure of ureteric bud branching and mesencymal condensation, and they died shortly after birth (7) .
In this study, we found marked changes in the degree of sulfation with PAN and IL-1␤ treatment but no significant changes in protein concentrations. This is in accordance with the observations of Holthöfer et al. (16) , who found similar effects of PAN on the sulfation of podocalyxin.
IL-1␤ is a proinflammatory cytokine that is involved in the acute-phase reaction during inflammation and is known to activate endothelial cells. In this study, we used one of the two available molecular forms of IL-1, IL-1␤. The two forms (IL-1␣ and IL-1␤) have similar effects and bind to the same receptors (9) . Our choice of IL-1␤ was based on a previous study on endothelial cell activation (44) . In that study, it was also shown that GECs synthesize IL-1␣ constitutively, but the major effects from IL-1␣ are usually thought to come from infiltrating macrophages. IL-1␤ has been shown to strongly and rapidly upregulate inflammatory mediators such as intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 (15, 43) . It has also been shown that IL-1␤ upregulates the expression of the neutral GAG hyaluronan in microvascular endothelium (28) . In addition to upregulating inflammatory mediators, we found that IL-1␤ also induced an increased synthesis of sulfated GAGs by the GECs, an effect that can be a part of the cell defense to maintain the permselective properties of the glomerular barrier (20) . There may, however, be differences between micro-and macrovascular endothelium, because the synthesis of GAGs was downregulated when porcine aortic endothelial cells were stimulated with IL-1␤ (36) .
In summary, the GECs produced sulfated GAGs with a hydrodynamic size of 50-90 Å. Heparan, chondroitin, and dermatan sulfate were the three main GAG components synthesized by bovine GECs. The rate of production of GAGs decreased during PAN treatment and increased during IL-1␤ treatment. We propose that the GAGs produced by the GECs may be a vital part of the glomerular charge barrier. Indeed, certain nephrotic conditions may actually be due to endothelial dysfunction, rather than pure renal disorders.
